Telia Co. Backs Guidance But Cautions on Costs
By Dominic Chopping
STOCKHOLM--Telia Co. AB on Wednesday posted a first-quarter net profit that missed forecasts and cautioned that inflation pressure is likely to hurt its cost targets, but the company backed its full-year guidance.
The Swedish telecommunications operator said it made a first-quarter net profit attributable to shareholders of 603 million kronor ($58.5 million), compared with SEK929 million a year earlier and the SEK1.16 billion expected in a FactSet poll.
Adjusted earnings before interest, taxes, depreciation and amortization--the company's preferred metric, which strips out exceptional and other one-off items--rose 0.8% to SEK7.26 billion, compared with an expected SEK7.28 billion.
Revenue rose 5.7% to SEK23.07 billion, against SEK22.38 billion expected.
"With energy headwinds starting to subside, pricing initiatives in place, and peak network investment now behind us, 2023 is a year for us to restore confidence in our strategy and improve cash generation, despite current challenges in TV and media," Chief Executive Allison Kirkby said.
"Heightened and continued inflationary pressure is masking the underlying cost take-out, and this is likely to impact our 2021-23 cost ambition."
Telia still expects like-for-like 2023 service revenue to grow by a low single digit, and adjusted Ebitda growth to be between flat and a low single digit percentage.
Write to Dominic Chopping at dominic.chopping@wsj.com
(END) Dow Jones Newswires
April 26, 2023 02:12 ET (06:12 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth